tirzepatide fatty liver disease Effect of versus insulin degludec on fat content and abdominal adipose tissue Metabolic dysfunction–associated steatotic liver disease

Candidacy depends on donor safety, disease stability and long-term planning

The frequency differed between the study groups, and some participants discontinued treatment because of adverse events

While GLP-1s excel in weight loss, glycemic control, and stroke prevention, SGLT2 inhibitors offer unmatched benefits in heart failure, CV death reduction, and renal protection

Caruso A, Cutuli VM, De Bernardis E, et al

There is likely a point of diminishing returns where additional receptor activation produces marginal benefit at disproportionate risk

For example, they may make different doses than are available by the brand